Skip to main content
SpringerLink
Log in

Release Mechanisms Behind Polysaccharides-Based Famotidine Controlled Release Matrix Tablets

  • Oral Controlled Release Development and Technology
  • Published:
AAPS PharmSciTech Aims and scope Submit manuscript

Abstract

Polysaccharides, which have been explored to possess gelling properties and a wide margin of safety, were used to formulate single-unit floating matrix tablets by a direct compression technique. This work has the aim to allow continuous slow release of famotidine above its site of absorption. The floating approach was achieved by the use of the low density polypropylene foam powder. Polysaccharides (κ-carrageenan, gellan gum, xyloglucan, and pectin) and blends of polysaccharides (κ-carrageenan and gellan gum) and cellulose ethers (hydroxypropylmethyl cellulose, hydroxypropylcellulose, sodium carboxymethyl cellulose) were tried to modulate the release characteristics. The prepared floating tablets were evaluated for their floating behavior, matrix integrity, swelling studies, in vitro drug release studies, and kinetic analysis of the release data. The differential scanning calorimetry and Fourier transform infrared spectroscopy studies revealed that changing the polymer matrix system by formulation of polymers blends resulted in formation of molecular interactions which may have implications on drug release characteristics. This was obvious from the retardation in drug release and change in its mechanistics.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

References

  1. A. Bartkowiak, and D. Hunkeler. Carrageenan–oligochitosan microcapsules: optimization of the formation process. Colloids Surf. B Biointerfaces. 21:285–298 (2001).

    Article  PubMed  CAS  Google Scholar 

  2. K. M. Picker. Matrix tablets of carrageenans. ΙΙ. Release behavior and effect of added cations. Drug Dev. Ind. Pharm. 25:339–346 (1999).

    Article  PubMed  CAS  Google Scholar 

  3. S. Miyazaki, N. Kawasaki, W. Kubo, K. Endo, and D. Attwood. Comparison of in situ gelling formulations for the oral delivery of cimetidine. Int. J. Pharm. 220:161–168 (2001).

    Article  PubMed  CAS  Google Scholar 

  4. K. Nishinari, K. Yamatoya, and M. Shirakawa. Xyloglucan. In G. O. Phillips, and P. A. Williams (eds.), Handbook of Hydrocolloids, CRC, Boca Raton, 2000, pp. 247–267.

    Google Scholar 

  5. C. Rolin. Pectin. In R. L. Whistler, and J. N. Bemiller (eds.), Industrial Gums: Polysaccharides and their Derivatives, Academic, New York, NY, 1993, pp. 257–293.

    Google Scholar 

  6. J. Nerurkar, H. W. Jun, J. C. Price, and M. O. Park. Controlled-release matrix tablets of ibuprofen using cellulose ethers and carrageenans: effect of formulation factors on dissolution rates. Eur. J. Pharm. Biopharm. 61:56–68 (2005).

    Article  PubMed  CAS  Google Scholar 

  7. S. Sungthongjeen, T. Pitaksuteepong, A. Somsiri, and P. Sriamornsak. Studies on pectins as potential hydrogel matrices for controlled-release drug delivery. Drug Dev. Ind. Pharm. 25:1271–1276 (1999).

    Article  PubMed  CAS  Google Scholar 

  8. Y. D. Sanzgiri, S. Maschi, V. Crescenzi, L. Callegaro, E. M. Topp, and V. J. Stella. Gellan-based systems for ophthalmic sustained delivery of methylprednisolone. J. Control. Release. 26:195–201 (1993).

    Article  CAS  Google Scholar 

  9. S. A. Agnihorti, S. S. Jawalkar, and T. M. Aminabhavi. Controlled release of cephalexin through gellan gum beads: effect of formulation parameters on entrapment efficiency, size, and drug release. Eur. J. Pharm. Biopharm. 63:249–261 (2006).

    Article  Google Scholar 

  10. P. S. Rajinikanth, J. Balasubramaniam, and B. Mistral. Development and evaluation of a novel floating in situ gelling system of amoxicillin for eradication of Helicobacter pylori. Int. J. Pharm. 335:114–122 (2006).

    Article  PubMed  Google Scholar 

  11. S. Miyazaki, F. Suisha, N. Kawasaki, M. Shirakawa, K. Yamatoya, and D. Attwood. Thermally reversible xyloglucan gels as vehicles for rectal drug delivery. J. Control Release. 56:75–83 (1998).

    Article  PubMed  CAS  Google Scholar 

  12. F. Suisha, N. Kawasaki, S. Miyazaki, M. Shirakawa, K. Yamatoya, M. Sasaki, and D. Attwood. Xyloglucan gels as sustained release vehicles for the intraperitoneal administration of mitomycin C. Int. J. Pharm. 172:27–32 (1998).

    Article  CAS  Google Scholar 

  13. N. Kawasaki, R. Ohkura, S. Miyazaki, Y. Uno, S. Sugimoto, and D. Attwood. Thermally reversible xyloglucan gels as vehicles for oral drug delivery. Int J Pharm. 181:227–234 (1999).

    Article  PubMed  CAS  Google Scholar 

  14. C. Dollery. In: Therapeutic Drugs, volume Ι, 2nd edition, Churchill Livingstone, Edinburgh London New York Philadelphia San Francisco Sydney Toranto; 1999.

  15. B. Mehta, M. M. Doshi, M. D. Joshi. Floating osmotic device for controlled release drug delivery. US Patent. 2003;20030064101.

  16. Y. F. Hui, J. Kolars, Z. Hu, and D. Fleisher. Intestinal clearance of H2-antagonists. Biochem. Pharmacol. 48:229 (1994).

    PubMed  CAS  Google Scholar 

  17. J. T. Fell, L. Whitehead, and J. H. Collet. Prolonged gastric retention using floating dosage forms. Pharm. Technol. 24(3):82–87 (2000).

    CAS  Google Scholar 

  18. L. Illum, and P. He. Gastroretentive controlled release microspheres for improved drug delivery. US Patent 2001;6,207,197.

    Google Scholar 

  19. P. Dettmar, P. A. Dickson, F. C. Hampson, I. G. Jollife, and W. Peers. Mucoadhesive granules of carbomer suitable for oral administration of drugs. US Patent 2001;6,306,789.

    Google Scholar 

  20. M. Jaimini, A. C. Rana, and Y. S. Tanwar. Formulation and evaluation of famotidine floating tablets. Current Drug Delivery. 4(1):51–55 (2007).

    Article  PubMed  CAS  Google Scholar 

  21. A. Streubel, J. Siepmann, and R. Bodmeier. Floating matrix tablets based on low density foam powder: effects of formulation and processing parameters on drug release. Eur. J. Pharm. Sci. 18:37–45 (2003).

    Article  PubMed  CAS  Google Scholar 

  22. P. L. Bardonnet, V. Faivre, W. J. Pugh, J. C. Piffaretti, and F. Falson. Gastroretentive dosage forms: Overview and special case of Helicobacter pylori. J. Control Release. 111:1–18 (2006).

    Article  PubMed  CAS  Google Scholar 

  23. M. Rosa, H. Zia, and T. Rhodes. Dosing and testing in-vitro of a bioadhesive and floating drug delivery system for oral application. Int. J. Pharm. 105:65–70 (1994).

    Article  Google Scholar 

  24. P. L. Ritger, and N. A. Peppas. A simple equation for description of solute release ΙΙ. Fickian and anomalous release from swellable devices. J. Control Release. 5:37–42 (1987).

    Article  CAS  Google Scholar 

  25. L. Vachoud, N. Zydowicz, and A. Domard. Physicochemical behavior of chitin gels. Carbohydr. Res. 326:295–304 (2000).

    Article  PubMed  CAS  Google Scholar 

  26. B. Saša, P. Odon, S. Stane, and K. Julijana. Analysis of surface properties of cellulose ethers and drug release from their matrix tablets. Eur. J. Pharm. Sci. 27:375–383 (2006).

    Article  PubMed  Google Scholar 

  27. D. A. Alderman. A review of cellulose ethers in hydrophilic matrices for oral controlled-release dosage forms. Int. J. Pharm. 5(3):1–9 (1984).

    CAS  Google Scholar 

  28. J. Timmermans, and A. J. Moes. The cutoff size for gastric emptying of dosage forms. J. Pharm. Sci. 828:854 (1993).

    Article  PubMed  CAS  Google Scholar 

  29. G. Chawla, P. Gupta, V. Koradia, and A. K. Bansal. Gastroretention: a means to address regional variability in intestinal drug absorption. Pharm. Tech. 27:50–68 (2003).

    Google Scholar 

  30. P. Sher, G. Ingavle, S. Ponrathnam, and A. P. Pawar. Low density porous carrier: Drug adsorption and release study by response surface methodology using different solvents. Int. J. Pharm. 331:72–83 (2007).

    Article  PubMed  CAS  Google Scholar 

  31. T. W. Wong, H. Y. Lee, L. W. Chan, and P. W. S. Heng. Drug release properties of pectinate microspheres prepared by emulsification method. Int J Pharm. 242:233–237 (2002).

    Article  PubMed  CAS  Google Scholar 

  32. Y. Pranoto, C. M. Lee, and H. J. Park. Characterizations of fish gelatin films added with gellan and κ-carrageenan. LWT. 40:766–774 (2007).

    Article  CAS  Google Scholar 

  33. A. S. Hussain, R. D. Johnson, P. Shivanand, and M. A. Zoglio. Effects of blending a nonionic and an anionic cellulose ether polymer on drug release from hydrophilic matrix capsules. Drug Dev. Ind. Pharm. 20(17):2645–2657 (1994).

    Article  CAS  Google Scholar 

  34. M. G. Sankalia, R. C. Mashru, J. M. Sankalia, and V. B. Sutariya. Stability improvement of alpha-amylase entrapped in kappa-carrageenan beads: Physicochemical characterization and optimization using composite index. Int. J. Pharm. 312:1–14 (2006).

    Article  PubMed  CAS  Google Scholar 

  35. A. R. Menjoge, and M. G. Kulkarni. Mechanistic investigations of phase behavior in Eudragit® E blends. Int. J. Pharm. 343:106–121 (2007).

    Article  PubMed  CAS  Google Scholar 

  36. B. N. Singh, and K. H. Kim. Characterization and relevance of physicochemical interactions among components of a novel multiparticulate formulation for colonic delivery. Int. J. Pharm. 341:143–151 (2007).

    Article  PubMed  CAS  Google Scholar 

  37. K. S. Bhise, R. S. Dhumal, B. Chauhan, A. Paradkar, and S. S. Kadam. Effect of oppositely charged polymer and dissolution medium on swelling, erosion, and drug release from chitosan matrices. AAPS PharmSciTech. 2007 8(2):article 44(E1–E9).

    Article  Google Scholar 

  38. B. Hegedus, P. Bod, K. Harsanyi, I. Peter, A. Kalman, and L. Parkanyi. Comparison of the polymorphic modifications of famotidine. J. Pharma. Biomed. Anal. 7:563 (1989).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmaceutics, Faculty of Pharmacy, Ain Shams University, Monazamet El Wehda El Afrikia St., El Abbassia, Cairo, Egypt

    Enas M. Elmowafy, Gehanne A. S. Awad, Samar Mansour & Abd El-Hamid A. El-Shamy

Authors
  1. Enas M. Elmowafy
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gehanne A. S. Awad
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Samar Mansour
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Abd El-Hamid A. El-Shamy
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Samar Mansour.

Additional information

Guest Editors: Stephen A. Howard and Jian-Xin Li

Rights and permissions

Reprints and permissions

About this article

Cite this article

Elmowafy, E.M., Awad, G.A.S., Mansour, S. et al. Release Mechanisms Behind Polysaccharides-Based Famotidine Controlled Release Matrix Tablets. AAPS PharmSciTech 9, 1230–1239 (2008). https://doi.org/10.1208/s12249-008-9155-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1208/s12249-008-9155-4

Key words

Search

Navigation